Scancell Holdings plc
SCNLF · OTC
4/30/2025 | 10/31/2024 | 4/30/2024 | 10/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.38 | -0.01 | -0.39 | 0.15 |
| FCF Yield | -1.12% | -3.21% | -9.34% | -5.95% |
| EV / EBITDA | -30.21 | -15.70 | -24.04 | -44.60 |
| Quality | ||||
| ROIC | -35.84% | -17,008.06% | -31.61% | -28.01% |
| Gross Margin | 94.95% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | -6.19 | 0.40 | 2.79 | 2.61 |
| Growth | ||||
| Revenue 3-Year CAGR | 1,676,274.46% | 1,740,227.59% | 1,740,227.59% | 1,740,227.59% |
| Free Cash Flow Growth | 70.97% | 47.19% | -41.18% | -62.15% |
| Safety | ||||
| Net Debt / EBITDA | 0.15 | -0.63 | -1.15 | -2.53 |
| Interest Coverage | -5.97 | -16.63 | -17.03 | -16.47 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -229.16 | 0.00 | -247.16 | -520.71 |